文献速递甲状腺核医学核素与放射性配体治疗

放射性碘与射频消融治疗自主功能性甲状腺结节的系统评价与对比Meta分析

Radioiodine versus radiofrequency ablation to treat autonomously functioning thyroid nodules: a systematic review and comparative meta-analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-02-02

该系统评价与对比Meta分析纳入23篇文章(28份报告),评估放射性碘(RAI)与射频消融(RFA)治疗自主功能性甲状腺结节(AFTN)的疗效。RAI治疗反应率(94%)显著高于RFA(59%),但结节体积缩小程度相似;直接比较(n=3项研究)显示RFA无应答风险高于RAI(RR,1.24;95%CI,0.94-1.63;z=1.55;p=0.12)。结论认为RAI在成功率和安全性方面优于RFA,确认RAI为AFTN治疗的首选。

要点

  • RAI治疗反应率94%显著高于RFA的59%,但结节体积缩小程度相似。
  • 直接比较(n=3项研究)显示RFA无应答风险高于RAI(RR,1.24;95%CI,0.94-1.63;p=0.12)。
  • 作者结论认为RAI在成功率和安全性方面优于RFA,是AFTN治疗的首选。

核心结论

  • 作者结论认为RAI在成功率和安全性方面优于RFA,确认RAI为AFTN治疗的首选。

研究设计与样本

  • 系统评价与对比Meta分析,检索PubMed、Web of Science、Scopus、Cochrane Library和ClinicalTrials.gov截至2023年7月,无时间或语言限制。
  • 纳入研究RAI和/或RFA治疗AFTN患者后6和/或12个月治疗反应的研究,共23篇文章(28份报告)符合纳入标准。
  • 基于研究设计评估偏倚风险,Meta分析采用随机效应模型。

主要发现

  • RAI治疗反应率(94%)显著高于RFA(59%),但AFTN体积缩小程度相似。
  • 直接比较(n=3项研究)显示RFA无应答风险高于RAI(RR,1.24;95%CI,0.94-1.63;z=1.55;p=0.12)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radioiodine (RAI) is a well-established first-line therapy for autonomously functioning thyroid nodules (AFTN). Radiofrequency ablation (RFA) is a minimally invasive procedure that has been proposed as an alternative treatment option for hyperthyroidism caused by AFTN. Although RFA has been shown to be useful for reducing nodule volume and improving TSH levels in AFTN, no comprehensive comparative clinical studies have been proposed to evaluate the overall response to RFA treatment. The aim of this comparative systematic review and meta-analysis was to evaluate the response of RAI and RFA treatments in AFTN. METHODS: A systematic search strategy was applied in PubMed, Web of Science, Scopus, Cochrane Library, and ClinicalTrials.gov until July 2023 without time or language restrictions. Studies investigating the response to RAI and/or RFA treatment in AFTN patients 6 and/or 12 months after treatment were included. The risk of bias was assessed based on the study design. Random-effect models were used for the meta-analysis. RESULTS: Twenty-three articles (28 reports) met the inclusion criteria and were included in the study. Overall, RAI therapy was found to have a significantly higher treatment response (94%) than RFA (59%), although the volume of AFTNs was reduced to a similar extent. In the direct comparison (n = 3 studies), RFA showed a higher risk of non-response than RAI (RR, 1.24; 95% CI, 0.94-1.63; z = 1.55; p = 0.12). CONCLUSIONS: Our results demonstrate the superiority of RAI over RFA in terms of success rates and safety profile and confirm RAI as the first choice for the treatment of AFTNs.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Giovanella L, Garo ML, Campenní A, et al. Radioiodine versus radiofrequency ablation to treat autonomously functioning thyroid nodules: a systematic review and comparative meta-analysis. Eur J Nucl Med Mol Imaging. 2024. PMID: 38305893. doi:10.1007/s00259-024-06625-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。